Clinical Outcomes with First-line Endocrine Therapy or Chemotherapy in Postmenopausal HR+/HER2− Metastatic Breast Cancer

OBJECTIVE: To describe patient profiles and clinical outcomes associated with first-line endocrine monotherapy (ET) and chemotherapy (CT) for postmenopausal HR+/HER2− metastatic breast cancer (mBC) patients. METHODS: This is a retrospective chart review of 139 postmenopausal HR+/HER2− mBC patients i...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yan, Hao, Yanni, Macalalad, Alexander R., Lin, Peggy L., Signorovitch, James E., Wu, Eric Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560455/
https://www.ncbi.nlm.nih.gov/pubmed/26380551
http://dx.doi.org/10.4137/BCBCR.S30771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560455/
https://www.ncbi.nlm.nih.gov/pubmed/26380551
http://dx.doi.org/10.4137/BCBCR.S30771

Ejemplares similares